Perioperative Systemic Immunotherapy (IO): Novel Regimens for Early-Stage Resectable NSCLC

Join us for a live webinar focused on the evolving role of immunotherapy in early-stage resectable non-small cell lung cancer (NSCLC). Led by expert faculty, including a thoracic surgeon and medical oncologist, this session will review the latest clinical guidelines and emerging data on perioperative immune checkpoint inhibitors. Participants will gain evidence-based insights on lung cancer screening, biomarker testing, and individualized perioperative treatment planning, with practical approaches to multidisciplinary collaboration and management of treatment-related adverse events. The program will feature interactive polling and live Q&A to help translate new evidence into clinical practice.